Division of Gastroenterology

Rebecca Anglin


Assistant Professor, Departments of Medicine and Psychiatry and Behavioural Neurosciences





Academic Biography

Dr. Rebecca Anglin obtained her MD from McMaster University in 2005 and completed her Psychiatry residency training in 2010 and the Clinician Investigator Training Program in 2012, both at McMaster University. She was awarded her PhD in Medical Sciences (Neuroscience and Behavioural Sciences) in 2012. Dr. Anglin currently holds a joint appointment as an Assistant Professor in the Departments of Psychiatry & Behavioural Neurosciences and Medicine at McMaster University. Her clinical and academic work is with the Gastroenterology division at McMaster University, where she sees patients with gastrointestinal disorders and psychiatric co morbidities and is developing a comprehensive and integrated clinical and research program focused on gut-brain interactions

Research Interests

Her research interests include the psychiatry of gastrointestinal disorders and gut-brain interactions and mitochondrial involvement in psychiatric illness. She also has a background in neuroimaging in psychiatric illness and is involved in studies looking at the neurobiology of women’s mental health, ethnicity and women’s mental health and postgraduate OSCE training and evaluation.

Selected Publications

  1. Anglin R, Samaan Z, Walter S, McDonald S. Depression and Vitamin D: A Systematic Review and Meta-analysis. British Journal of Psychiatry 2013 Feb; 202:100-7. Doi:10.1192/bjp.bp.111.106666
  2. Anglin RE, Rosebush PI, Noseworthy MD, Tarnopolsky M, Weber AM, Soreni N, Mazurek MF. Metabolite measurements in the caudate nucleus, anterior cingulate cortex and hippocampus among patients with mitochondrial disorders: a casecontrol study using proton magnetic resonance spectroscopy. CMAJ Open 2013. DOI: 10.9778/cmajo.20120020
  3. Anglin R, Rosebush PI, Noseworthy MD, Tarnopolsky M, Mazurek MF. Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders: A proton magnetic resonance spectroscopy study. Translational Psychiatry 2012 Nov 13;2:e187. doi: 10.1038/tp.2012.107
  4. Anglin R, Tarnopolsky M, Mazurek MF, Rosebush PI. The Psychiatric Presentation of Mitochondrial Disorders in Adults. Journal of Neuropsychiatry and Clinical Neurosciences 2012 Sep 1;24(4):394-409. doi: 10.1176/appi.neuropsych.11110345
  5. Anglin R, Rosebush P, Mazurek M. Psychotropic medications and mitochondrial toxicity. Nature Reviews Neurosciences [letter] 2012 Jul 25; doi 10.1038/nrn3229-c1
  6. Anglin R, Mazurek MF, Tarnopolsky M, Rosebush PI. The Mitochondrial Genome and Psychiatric Illness. American Journal of Medical Genetics: Neuropsychiatric Genetics 2012 Aug 6. Doi:10.1002/ajmg.b.32086
  7. Anglin RE, Garside S, Tarnopolsky M, Mazurek MF, Rosebush PI. The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature. Journal of Clinical Psychiatry 2012; 73(4):506-512
  8. Anglin R, Rosebush PI, Mazurek MF. Neuroleptic Malignant Syndrome: A Neuroimmunologic Hypothesis. Canadian Medical Association Journal 2010:182(18): E834-8
  9. Kanji J, Anglin R, Hunt D, Panju A. Rational Clinical Examination: Does my patient with Diabetes have Peripheral Neuropathy? JAMA 2010;303(15): 1526-153
  10. Anglin R, Rosebush PI, Mazurek MF. Treating Psychiatric Illness in Patients with Mitochondrial Disorders. Psychosomatics 2010; 51(1): 179
  11. Rosebush PI, Anglin R, Mazurek MF. NMS and the Acute Phase Response. Journal of Clinical Psychopharmacology 2008; 28(4): 459-461
  12. Anglin R, Rosebush PI and Mazurek MF. The Neuropsychiatric Profile of Addison’s Disease: Revisiting a Forgotten Phenomenon. Journal of Neuropsychiatry and Clinical Neuroscience. 2006;18:450-459.